Antonello Veccia

1.6k total citations
66 papers, 739 citations indexed

About

Antonello Veccia is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Antonello Veccia has authored 66 papers receiving a total of 739 indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Pulmonary and Respiratory Medicine, 39 papers in Oncology and 18 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Antonello Veccia's work include Prostate Cancer Treatment and Research (42 papers), Radiopharmaceutical Chemistry and Applications (17 papers) and Lung Cancer Treatments and Mutations (13 papers). Antonello Veccia is often cited by papers focused on Prostate Cancer Treatment and Research (42 papers), Radiopharmaceutical Chemistry and Applications (17 papers) and Lung Cancer Treatments and Mutations (13 papers). Antonello Veccia collaborates with scholars based in Italy, United States and Ukraine. Antonello Veccia's co-authors include Orazio Caffo, Francesca Maines, Enzo Galligioni, Stefania Kinspergher, Gaetano Facchini, Ugo De Giorgi, Lucianna Russo, Vincenzo Emanuele Chiurì, Vincenza Conteduca and Michele Aieta and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and Urology.

In The Last Decade

Antonello Veccia

60 papers receiving 727 citations

Peers

Antonello Veccia
Francis Parnis Australia
Franck Priou France
Elisa Zanardi Italy
Zafeiris Zafeiriou United Kingdom
Satoshi Fukasawa Japan
F. Gómez-Veiga Spain
Preston Gable United States
C Mossetti Italy
Y. Hei United States
Daniel Buergy Germany
Francis Parnis Australia
Antonello Veccia
Citations per year, relative to Antonello Veccia Antonello Veccia (= 1×) peers Francis Parnis

Countries citing papers authored by Antonello Veccia

Since Specialization
Citations

This map shows the geographic impact of Antonello Veccia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antonello Veccia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antonello Veccia more than expected).

Fields of papers citing papers by Antonello Veccia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Antonello Veccia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antonello Veccia. The network helps show where Antonello Veccia may publish in the future.

Co-authorship network of co-authors of Antonello Veccia

This figure shows the co-authorship network connecting the top 25 collaborators of Antonello Veccia. A scholar is included among the top collaborators of Antonello Veccia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Antonello Veccia. Antonello Veccia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Casagrande, Silvia, Giovanni Bertalot, Roberto Bortolotti, et al.. (2024). Immune-Related Adverse Events Due to Cancer Immunotherapy: Immune Mechanisms and Clinical Manifestations. Cancers. 16(7). 1440–1440. 33 indexed citations
2.
Russo, Anna, Claudio Sini, Diego Cortinovis, et al.. (2024). 1301P BRAF-mutant metastatic non-small cell lung cancer: Real-world data from the Italian biomarker ATLAS database. Annals of Oncology. 35. S828–S828.
3.
4.
Inno, Alessandro, Antonello Veccia, Alvise Berti, et al.. (2024). Risk of cardiovascular toxicity with combination of immune-checkpoint inhibitors and angiogenesis inhibitors: a meta-analysis. Frontiers in Cardiovascular Medicine. 11. 1309100–1309100. 1 indexed citations
5.
6.
Cortiula, Francesco, Giulia Pasello, Alessandro Follador, et al.. (2020). A Multi-Center, Real-Life Experience on Liquid Biopsy Practice for EGFR Testing in Non-Small Cell Lung Cancer (NSCLC) Patients. Diagnostics. 10(10). 765–765. 6 indexed citations
7.
Tucci, Marcello, Orazio Caffo, Consuelo Buttigliero, et al.. (2019). Therapeutic options for first-line metastatic castration-resistant prostate cancer: Suggestions for clinical practise in the CHAARTED and LATITUDE era. Cancer Treatment Reviews. 74. 35–42. 22 indexed citations
8.
Messina, Carlo, Valeria Merz, M. Frisinghelli, et al.. (2019). Adjuvant chemotherapy in resected bile duct cancer: A systematic review and meta-analysis of randomized trials. Critical Reviews in Oncology/Hematology. 143. 124–129. 20 indexed citations
9.
Conteduca, Vincenza, Orazio Caffo, Cristian Lolli, et al.. (2017). Long‐term clinical impact of PSA surge in castration‐resistant prostate cancer patients treated with abiraterone. The Prostate. 77(9). 1012–1019. 7 indexed citations
10.
Veccia, Antonello, Francesca Maines, Stefania Kinspergher, Enzo Galligioni, & Orazio Caffo. (2017). Cardiovascular toxicities of systemic treatments of prostate cancer. Nature Reviews Urology. 14(4). 230–243. 14 indexed citations
11.
Murgia, Viviana, Antonello Veccia, S. Brugnara, et al.. (2017). Weekly paclitaxel after first-line failure in patients with advanced non-small-cell lung cancer. Anti-Cancer Drugs. 28(6). 654–659. 1 indexed citations
12.
Veccia, Antonello, Francesca Maines, & Orazio Caffo. (2017). Cardiovascular toxicities of systemic treatments of prostate cancer: is oestrogen to the rescue?. Nature Reviews Urology. 14(9). 575–575. 3 indexed citations
13.
Caffo, Orazio, Francesca Maines, Mimma Rizzo, Stefania Kinspergher, & Antonello Veccia. (2016). Metastatic castration-resistant prostate cancer in very elderly patients: challenges and solutions. Clinical Interventions in Aging. Volume 12. 19–28. 9 indexed citations
14.
Caffo, Orazio, Francesca Maines, Antonello Veccia, Stefania Kinspergher, & Enzo Galligioni. (2016). Splice variants of androgen receptor and prostate cancer. Oncology Reviews. 10(1). 297–297. 5 indexed citations
15.
16.
Caffo, Orazio, Francesca Maines, Davide Donner, et al.. (2014). Impact of Enzalutamide Administration on Primary Prostate Cancer Volume: A Metabolic Evaluation by Choline Positron Emission Tomography in Castration-Resistant Prostate Cancer Patients. Clinical Genitourinary Cancer. 12(5). 312–316. 18 indexed citations
17.
Caffo, Orazio, et al.. (2013). An evaluation of the pharmacokinetics and clinical use of vinorelbine for NSCLC treatment. Expert Opinion on Drug Metabolism & Toxicology. 9(8). 1037–1051. 11 indexed citations
18.
Caffo, Orazio, Giovanni Pappagallo, S. Brugnara, et al.. (2012). Multiple Rechallenges for Castration-resistant Prostate Cancer Patients Responding to First-line Docetaxel: Assessment of Clinical Outcomes and Predictive Factors. Urology. 79(3). 644–649. 42 indexed citations
19.
Caffo, Orazio, Teodoro Sava, Evi Comploj, et al.. (2011). Impact of docetaxel‐based chemotherapy on quality of life of patients with castration‐resistant prostate cancer: results from a prospective phase II randomized trial. British Journal of Urology. 108(11). 1825–1832. 20 indexed citations
20.
Caffo, Orazio, Lucia Fratino, Alessandra Perin, et al.. (2011). Pemetrexed as second-line chemotherapy for castration-resistant prostate cancer after docetaxel failure: Results from a phase II study. Urologic Oncology Seminars and Original Investigations. 31(2). 180–186. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Francis Parnis Breakdown of academic impact, for papers by Franck Priou Breakdown of academic impact, for papers by Elisa Zanardi Breakdown of academic impact, for papers by Zafeiris Zafeiriou Breakdown of academic impact, for papers by Satoshi Fukasawa Breakdown of academic impact, for papers by F. Gómez-Veiga Breakdown of academic impact, for papers by Preston Gable Breakdown of academic impact, for papers by C Mossetti Breakdown of academic impact, for papers by Y. Hei Breakdown of academic impact, for papers by Daniel Buergy
Rankless by CCL
2026